Skip to main content
TipRanks
Go Ultimate75% OFF

ProMIS Neurosciences (23J) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

23J Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to ProMIS Neurosciences in the past 3 months

23J Stock 12 Month Forecast

€14.91▲(414.30% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for ProMIS Neurosciences in the last 3 months. The average price target is EUR 14.91 with a high forecast of EUR 16.27 and a low forecast of EUR 13.56. The average price target represents a 414.30% change from the last price of EUR 2.90.
Highest Price Target€16.27Average Price Target€14.91Lowest Price Target€13.56

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:23J
Price TargetArticle
Roth MKM€13.56buy367.55%UpsideReiterated11/13/26
H.C. Wainwright€16.27buy461.06%UpsideReiterated11/09/26
Guggenheim€62.37→€90.39buy3017.00%UpsideReiterated08/14/26
Maxim Group€31.64buy990.95%UpsideReiterated08/14/26
Chardan Capital€29.83buy928.61%UpsideReiterated08/13/26
Cantor Fitzgerald€35.93buy1139.01%UpsideInitiated06/29/26
Brookline Capital Markets Analyst forecast on DE:23JUnknown AnalystNot RankedBrookline Capital Markets€36.16buy1146.80%UpsideInitiated05/20/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HROWHarrow Health
PLSEPulse Biosciences
DFTXDefinium Therapeutics
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ProMIS Neurosciences

3 Months
Jason McCarthy
Jason McCarthyMaxim Group
Success Rate4/9 ratings generated profit
44%
Average Return
+3.81%

Copying Jason McCarthy's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +3.81% per trade.

1 Year
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate1/7 ratings generated profit
14%
Average Return
-46.91%

Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -46.91% per trade.

2 Years
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate0/7 ratings generated profit
0%
Average Return
-58.09%

Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -58.09% per trade.

23J Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 23J
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1112965
Buy22200
Hold00000
Sell00000
Strong Sell00000
total13141165

In the current month, 23J has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 23J average Analyst price target in the past 3 months is 14.91.

23J Financial Forecast

€-5€-3.75€-2.5€-1.25€0Q1 2026Q3 2026Q4 2026
High€-0.78
Consensus€-0.93
Low€-1.22

23J Earnings Forecast

Next quarter’s earnings estimate for 23J is -EUR 0.93 with a range of -EUR 1.22 to -EUR 0.78. The previous quarter’s EPS was -EUR 0.81. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€-1€-0.5€0€0.5€1Q1 2026Q3 2026Q4 2026
High€0.00
Consensus€0.00
Low€0.00

23J Sales Forecast

Next quarter’s sales forecast for 23J is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

23J Stock Forecast FAQ

What is DE:23J’s average 12-month price target, according to analysts?
Based on analyst ratings, ProMIS Neurosciences’s 12-month average price target is €14.91.
What is DE:23J’s upside potential, based on the analysts’ average price target?
ProMIS Neurosciences has 414.30% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ProMIS Neurosciences a Buy, Sell or Hold?
ProMIS Neurosciences has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is ProMIS Neurosciences’s share price target?
The average share price target for ProMIS Neurosciences is €14.91. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €16.27, and the lowest forecast is €13.56. The average share price target represents a 414.30% increase from the current price of €2.9.
What do analysts say about ProMIS Neurosciences?
ProMIS Neurosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of ProMIS Neurosciences?
To buy shares of DE:23J, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.